Table of Content - Pyrimethamine Market

Pyrimethamine is a medicine used to treat protozoan infections. Pyrimethamine belongs to a class of drugs known as antiparasitics. It works by killing parasites. It is commonly used as an antimalarial (for the treatment and prevention of malaria), as well as to treat Toxoplasma gondii infections, and it is also used in combination with the antibiotic sulfa sulfadiazine for the treatment of human immunodeficiency virus (HIV) positive people. Toxoplasmosis is a serious, life-threatening, and sometimes fatal infection. The Centers for Disease Control and Prevention (CDC) has recognized toxoplasmosis as one of the five neglected parasitic infections. A large number of people are infected with toxoplasmosis; however, only a few patients will have serious complications. The routes of transmission of Toxoplasma gondii infection are food, contact with animals (cats), water, soil, and others.

As pyrimethamine is resistant to many Plasmodium species, it is generally administered in conjunction with sulfa and folinic acid. Pyrimethamine has also been found to limit the expression of the gene for superoxide dismutase 1, a protein associated with amyotrophic lateral sclerosis.

Market Dynamics

The increasing number of HIV patients worldwide is anticipated to drive the growth of the global pyrimethamine market over the forecast period. For instance, according to the global HIV statistics fact sheet published by The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, globally, there were 37.7 million (30.2 million–45.1 million) people living with HIV, out of which 36.0 million (28.9 million–43.2 million) were adults, 1.7 million (1.2 million–2.2 million) were children aged between 0–14 years, and 53% of all people living with HIV were women and girls.

Key features of the study:

This report provides an in-depth analysis of the global pyrimethamine market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pyrimethamine market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Vyera Pharmaceuticals, LLC, Cerovene Healthcare PVT LTD, GlaxoSmithKline plc, Impax Laboratories, Inc., NCBO BioPortal, Pfizer, Inc., PRN Pharmacal, SUDA Pharmaceuticals, Taj Accura Pharmaceuticals, TargetMo Chemicals Inc., Evaluate Ltd., and Abcam
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pyrimethamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pyrimethamine market

Detailed Segmentation:

Global Pyrimethamine Market, By Indication:
- Toxoplasmosis
- Malaria
- Others
Global Pyrimethamine Market, By Route of Administration:
- Parenteral
- Oral
Global Pyrimethamine Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Pyrimethamine Market, By Region:
- North America
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Vyera Pharmaceuticals, LLC.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cerovene Healthcare PVT. LTD
- GlaxoSmithKline plc.
- Impax Laboratories, Inc.
- NCBO BioPortal
- Pfizer, Inc.
- PRN Pharmacal
- SUDA Pharmaceuticals
- Taj Accura Pharmaceuticals
- TargetMo Chemicals Inc.
- Evaluate Ltd.
- Abcam

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Indication
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
  - Market Opportunity Map
Global Pyrimethamine Market Insights
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Industry Trends
- New Product Launches
- Key Development
- Regulatory Scenario
- Collaborations & Acquisitions
- Epidemiology
- PEST Analysis
- Porter’s five forces analysis
Global Pyrimethamine Market– Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact of COVID-19 on demand and supply chain
Global Pyrimethamine Market, By Indication, 2017 – 2030 (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Toxoplasmosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030 (US$ Mn)
- Malaria
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030 (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030 (US$ Mn)
Global Pyrimethamine Market, By Route of Administration, 2017 – 2030 (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Parenteral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030 (US$ Mn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030 (US$ Mn)
Global Pyrimethamine Market, By Distribution Channel, 2017 – 2030 (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
Global Pyrimethamine Market, By Region, 2017 – 2030 (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 – 2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Mn)
  - Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Mn)
  - Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Mn)
  - Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Mn)
  - Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Mn)
  - Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017–2030, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017–2030, (US$ Mn)
  - Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017–2030, (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Vyera Pharmaceuticals, LLC.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cerovene Healthcare PVT. LTD
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Impax Laboratories, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- NCBO BioPortal
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- PRN Pharmacal
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- SUDA Pharmaceuticals
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Taj Accura Pharmaceuticals
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- TargetMo Chemicals Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Evaluate Ltd.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abcam
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Section
- Research Methodology
- About us
- Contact

*Browse 35 market data tables and 29 figures on “Global Pyrimethamine Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount